IPR Waiver

TPCI _COVID_Vaccination
IPR waivers: The magic pills to decolonize vaccine access?

Clamor has risen around India & South Africa’s proposal seeking the waiver of Intellectual Property Rights (IPR) for easier access to COVID-19 medicines. But what choices do nations have if the nego...

Rashmi Banga, Senior Economic Officer, UNCTAD
Pharma industry is backing vaccine nationalism

Dr Rashmi Banga, Senior Economic Affairs Officer, UNCTAD, states that to move towards global vaccine equity, it is important for the governments to declare vaccines as a public good and not allow phar...

Professor Manoj Pant, Director, Indian Institute of Foreign Trade
COVID-19 & the IPR waiver: Will it work?

Prof Manoj Pant, Director, IIFT, argues that for once, the IPR waiver on COVID vaccines should be taken as a non-political necessity in response to a once-in-a-decade event. The long term political op...

Subscribe To Newsletter

Stay ahead in the dynamic world of trade and commerce with India Business & Trade's weekly newsletter.